Larvol Delta - Selective-Targeting-of-a-Maladaptive-AdipokineBut-Not-of-a-Traditional-Hemodynamic-PhenotypeProduces-Predicted-Left-Heart-Benefits-in-Patients-With-Heart-Failure-and-Preserved-Ejection-Fraction

Winrevair (sotatercept-csrk) - BMS, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42714366

Barry A Borlaug; Mardi Gomberg-Maitland; Milton Packer

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next